ClinicalTrials.Veeva

Menu

Characterization of a Clinical Subpopulation With Autism Spectrum Disorder

S

Stalicla

Status

Completed

Conditions

Autism Spectrum Disorder

Treatments

Other: Observation

Study type

Observational

Funder types

Industry

Identifiers

NCT04273087
STP1-C003

Details and patient eligibility

About

The main objective for this research study is to gather additional information to help confirm identification of new subgroups within the autism spectrum.

Enrollment

236 patients

Sex

All

Ages

10 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants previously diagnosed with ASD (DSM-5) supported by either autism diagnostic interview revised (ADI-R) or Autism Diagnostic Observation Scale (ADOS-2) scores
  • Available health records within the first 2 years of life
  • Participants must have a parent or reliable caregiver who agrees to provide information about the participant

Exclusion criteria

  • Genetically identified ASD (syndromic form of autism, e.g. fragile X)
  • Episode of fever (i.e. ≥100.5 °F) or clinically significant illness without fever (as judged by the Investigator), within 10 days before the study visit

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems